Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PROSPECTIVE, MULTICENTER, SINGLE-ARM TRIAL FOR THE NEW SIZES OF BRIDGE STENTS FOR VERTEBRAL ARTERY STENOSIS: Bridge-MAX

NCT06186024 is registered in ClinicalTrials.gov with MicroPort NeuroTech Co., Ltd. as lead sponsor.

NCT NCT06186024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06186024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PROSPECTIVE, MULTICENTER, SINGLE-ARM TRIAL FOR THE NEW SIZES OF BRIDGE STENTS FOR VERTEBRAL ARTERY STENOSIS: Bridge-MAX
Lead sponsor
MicroPort NeuroTech Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
September 27, 2023
Completion date
January 30, 2025
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain diseases, vertebral artery stenosis, vertebral artery thrombosis